the pharmacokinetics of daunorubicin were studied in 3 previously untreated patients with acute myeloblastic leukaemia by simultaneous monitoring of daunorubicin ( dnr ) , daunorubicinol ( dol ) and their aglycones in plasma , urine and leukaemic cells .
C0023467
acute myeloblastic leukaemia
C0011015
daunorubicin